AGREED!
We have been told adnauseum over the past 10 or more years that the whole company strategy was to licence off the DEP products once the proof of concept was achieved.......
Well here we are. Phase 2 Trials complete. Proof of concept achieved. And we are still having to go to conferences to flog off our products??
Just what have management been doing in these ongoing discussions?
Ann: Positive DEP docetaxel Phase 2 results, page-38
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.001(0.51%) |
Mkt cap ! $41.52M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.9¢ | $9.709K | 97.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 384741 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 493798 | 2 |
View Market Depth
| Last trade - 14.36pm 27/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |